PMcardio - ECG Analysis app analytics for December 3

PMcardio - ECG Analysis

PMcardio - ECG Analysis

  • Powerful Medical
  • Google Play Store
  • Free
  • Medical
PMcardio is an AI-powered medical solution that empowers healthcare professionals to interpret ECGs accurately in seconds and diagnose and treat 39 cardiovascular diseases with the confidence of an expert cardiologist. PMcardio is a Class IIb medical device certified under the EU MDR regulation. The app integrates human expertise with cutting-edge AI technology. PMcardio provides patient management and treatment recommendations based on clinical practice guidelines. Using the standardised traffic-light triage system, PMcardio enables users to triage patients more accurately. The clinical performance of PMcardio has been benchmarked against general practitioners and cardiologists. PMcardio has demonstrated improved diagnostic performance across all standard evaluation metrics. Key features: • ECG Digitisation: PMcardio converts any paper-form or screen-based image of an ECG into a standardised digital waveform. • ECG Interpretation: PMcardio reads any standard 12-lead ECG and diagnoses it with 38.8% average improved detection. • Treatment recommendations: PMcardio helps triage & manage patients better thanks to the traffic-light triage system and guideline-adherent treatment recommendations. • Diagnostic ECG reporting: PMcardio provides a full, professional ECG diagnostic report that can be exported and saved in a digital archive. DISCLAIMER: PMcardio is a CE-marked, Class IIb Medical Device under EU regulations. The product is intended to be used by qualified healthcare professionals for the assessment of cardiovascular diseases using ECG data. The application provides diagnostic and treatment recommendations for patients aged 18 years and above. The electronic instructions for use can be accessed in the about section within the application after logging in or using the link in the footer section of our website. If you are a registered customer, you can request a printed version of the instructions for use by contacting our support. After verifying your eligibility, the printed version of the instructions for use will be sent and delivered within seven days at no additional cost. Basic UDI-DI: 426073843PMcardio0001H2 Have questions, comments, or feedback? Please get in touch with us at support@powerfulmedical.com.
PMcardio - ECG Analysis

PMcardio - ECG Analysis Usage Rank

The usage rank is based on Similarweb's algorithm that calculates current installs and active users over a 28-day period.

All Categories in
United States--
Medical in
United States--

Daily active users

Analyze usage patterns of PMcardio - ECG Analysis users by viewing PMcardio - ECG Analysis downloads and daily active users over time.

Users

Analyze usage patterns of PMcardio - ECG Analysis users by viewing PMcardio - ECG Analysis downloads and daily active users over time.

Unlock daily active users
OctNovDec

PMcardio - ECG Analysis Ranking Stats Over Time

Similarweb's Usage Rank & Google Play Store Rank for PMcardio - ECG Analysis

Usage Rank

Rank

PMcardio - ECG Analysis Ranking by Country

Counties in which PMcardio - ECG Analysis has the highest ranking in its main categories


Users Interests & Top Categories

Top categories and apps used by PMcardio - ECG Analysis users

Top categories
Affinity
Top apps within the category
14%
Monarch: Budget & Track Money
Google Pay: Save and Pay
Ally: Bank, Auto & Invest
Chase Mobile
13%
DoorDash - Food Delivery
Papa Johns Pizza & Delivery
Chick-fil-A®
11%
New Innovations
Epic Haiku
10%
Google Meet
GroupMe
Google Messages
Gmail
Google Chrome

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

Washington Manual Psychiatry

Washington Manual Psychiatry

Skyscape Medpresso Inc

Kardia

Kardia

AliveCor Inc.

William Endocrinology Textbook

William Endocrinology Textbook

Skyscape Medpresso Inc

Qaly | ECG Reader

Qaly | ECG Reader

Qaly, Inc.

PMcardio - ECG Analysis VS.

December 3, 2024